Flash Finance

Indo Rama Synthetics (India) Limited (INDORAMA) — Multibagger Analysis

AI research on 1 Expansion / Order-win announcement by Indo Rama Synthetics (India) Limited since October 2026 — deal magnitude, revenue and EPS impact, execution risk, and the actual return since each announcement measured from the next trading day's open and benchmarked against the Nifty Smallcap 250.

1
Announcements analysed
0
Strong candidates
28/100
Best multibagger score
Indo Rama Synthetics (India) Limited — Stock analysis & AI research Indo Rama Synthetics (India) Limited — Quarterly results & fundamentals Indo Rama Synthetics (India) Limited — Seasonality — best & worst months Indo Rama Synthetics (India) Limited — Technical indicators & charts Indo Rama Synthetics (India) Limited — Technical setup — score, trend, support & resistance Indo Rama Synthetics (India) Limited — Live exchange announcements

Outcome of Board Meeting

· Expansion · Unlikely · Textiles - Manmade · score 28/100
Deal
Deal value₹200 Cr
Deal vs businesscapex = ₹200 Cr (4.4% of TTM revenue ₹4,541 Cr; 35.5% of net worth ₹564 Cr)
Size vs own revenue0.04×
Execution period1.5 yr
Fundamental gradeC
AI projections
Revenue uplift (yr1 / steady)2.5% / 7.7%
EPS uplift9.5%
Upside base / bull / bear12.0% / 45.0% / -48.0%
Horizon18-36 months
Realized market record
Entry — next-day open—
Latest close (16 Oct 2026)₹97.56
Return since—
α vs Smallcap 250—
Positives
  • Strategic product shift toward higher-margin speciality filament and fibre, reducing reliance on commoditized standard polyester.
  • Promoter backing from Indorama Ventures providing global supply chain integration and technical capability with a 75% holding.
  • Brownfield expansion at the existing Butibori (Nagpur) plant enables lower capex per ton and faster execution (12-18 months).
  • Sharp earnings turnaround from FY24 losses (-₹203 Cr) to FY26 PAT of ₹150 Cr and TTM PAT of ₹161 Cr.
Risks
  • Elevated balance sheet leverage with D/E of 1.69 (Debt ₹952 Cr on Net Worth ₹564 Cr); capex funding via debt will pressure cash flows.
  • Catalyst scale is small relative to business size (capex is only 4.4% of TTM revenue), delivering modest steady-state revenue addition (<8%).
  • High commodity cyclicality and extreme sensitivity to crude oil, PTA, and MEG price spreads, plus persistent threat of Chinese polyester dumping.
  • Valuation risk: Stock price has rallied 140.5% over the trailing 6 months, pushing P/E to 15.4x compared to the peer median of 8.8x.
Governance flags
  • High third-party/related-party supply dependence on TPT Petrochemicals (Thailand) for PTA (proposed limit of ₹800 Cr for FY26).
Full AI brief

1. Ramp-Aware Catalyst Impact Math

Indo Rama Synthetics has announced board approval for a ₹200 Cr expansion capex at its Butibori plant (Nagpur) via the company and its wholly owned subsidiary IVYPL to scale speciality filament and fibre production. The estimated Commercial Operation Date (COD) is 12 to 18 months.

  • Capex Scale vs Business: The ₹200 Cr capex represents 35.5% of net worth (₹564 Cr), which is significant from a balance sheet perspective, but only 4.4% of TTM revenue (₹4,541 Cr).
  • Asset Turnover & Revenue Potential: Specialty manmade fibre projects typically achieve an asset turnover of 1.6x to 1.8x at optimal utilization. At 1.75x turnover, peak incremental revenue capacity is ~₹350 Cr.
  • Execution & Ramp Schedule:
  • Months 0–18 (FY27–H1 FY28): Construction and commissioning. Revenue impact is 0%.
  • Year 1 Post-COD (H2 FY28–FY29): Initial commercial ramp at ~30–35% utilization yields ~₹115 Cr revenue (~2.5% uplift over TTM revenue).
  • Steady-State (FY30 onwards): 100% capacity utilization generates ~₹350 Cr incremental revenue (~7.7% uplift over TTM revenue).
  • Margin & EPS Contribution: Speciality fibres typically command higher operating margins (OPM ~13.5% vs. current blended ~7.1%).
  • Peak Incremental EBITDA = ₹350 Cr * 13.5% = ₹47.25 Cr.
  • Annual Depreciation (straight-line @ 7%) = ₹14.0 Cr.
  • Annual Interest cost (~₹130 Cr debt portion @ 10%) = ₹13.0 Cr.
  • Incremental PBT = ₹20.25 Cr; Incremental PAT (@ 25% tax) = ₹15.19 Cr.
  • TTM PAT is ₹161 Cr; this represents a steady-state EPS uplift of ~9.4% to 9.5% (~₹0.58 per share on TTM EPS of ₹6.18).

2. Industry Context & Capital Intensity

  • Industry: Textiles - Manmade (Polyester Staple Fibre, Filament Yarn, PTA).
  • Capital Intensity: HIGH. Substantial plant maintenance capex and working capital requirements are structural features.
  • Execution Difficulty: MEDIUM. The capex is brownfield at an operational site, lowering execution hurdles compared to greenfield projects. However, polyester chemistry and fibre drawing require stringent quality control.
  • Expected Industry CAGR: 5.0% - 7.0%. The industry is commoditized, mature, and exposed to cyclical swings driven by crude oil fluctuations and capacity expansions in China.

3. Multibagger Quality & SEPA Analysis

  • EPS Acceleration & Quality: FY24 saw a heavy net loss of -₹203 Cr, followed by a sharp cyclical recovery to ₹150 Cr in FY26. However, top-line momentum has stuttered (Jun 2026 consolidated revenue dropped to ₹936.6 Cr from ₹1,305.7 Cr in Jun 2025).
  • Balance Sheet Health: Net debt stands at ₹952 Cr against a net worth of ₹564 Cr, resulting in a high D/E of 1.69x. Adding term debt for this capex will keep debt service obligations elevated.
  • Return Ratios: ROCE of 16.0% is respectable, but it represents the upper band of a commodity upcycle rather than structural compounding moat.
  • SEPA Grade C: The company lacks sustained multi-year sales growth, operates in a price-taker commodity environment, and carries significant financial leverage.

4. Valuation & Scenario Calibration

  • Current Setup: At ₹95.4, INDORAMA trades at 15.4x trailing P/E, reflecting a significant premium over the textile peer median of 8.8x (Pasupati Acrylon, Filatex, Century Enka, etc.). The stock has already surged 140.5% in the last 6 months.
  • Bull Case (+45%, Target ₹138): Specialty margins exceed expectations (16% OPM), commodity spreads remain favorable, FY29 PAT reaches ~₹235 Cr (EPS ~₹9.0), and the market values the stock at 15x.
  • Base Case (+12%, Target ₹107): Capex delivers ~₹350 Cr top-line by FY29 with 13% OPM. Total PAT grows to ~₹190 Cr (EPS ~₹7.28). Multiple de-rates to a more sustainable 14.5x.
  • Bear Case (-48%, Target ₹50): Global crude/PTA spread compression recurs, debt servicing constraints mount, and revenue stalls. PAT drops to ~₹90 Cr (EPS ~₹3.45), re-rating toward the peer median of 10x-12x P/E.

5. Verdict Rationale

The capex of ₹200 Cr is a step in the right direction toward margin-accretive speciality products, but it is far too small (adding ~7.7% to revenue over 2-3 years) to serve as a multibagger catalyst for a ₹4,500+ Cr top-line business. Coupled with a stretched balance sheet (D/E 1.69), high sensitivity to raw material input costs, and a 140% 6-month stock rally that has pushed the valuation far above industry peers, the stock is categorized as UNLIKELY to deliver multibagger returns.

Analysis as of 2026-10-16 (price ₹95.44) · AI research, not investment advice.
FollowTelegram

Verdicts and projections on this page are produced by an AI model from Indo Rama Synthetics (India) Limited's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI